{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:28:42Z","timestamp":1787776122857,"version":"build-2784847793"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:sec>\n                    <jats:title>Context:<\/jats:title>\n                    <jats:p>\n                      In\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      fertilization (IVF) cycles, the recommended dose of recombinant human chorionic gonadotropin (r-hCG), for triggering final follicular maturation is 250 \u03bcg, although there is some disagreement.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>The aim of our study was to assess the effect on the number of mature oocytes retrieved after triggering ovulation in IVF cycles using 250 \u03bcg or 500 \u03bcg of r-hCG.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Settings and Design:<\/jats:title>\n                    <jats:p>Prospective, single-center, randomized study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Subjects and Methods:<\/jats:title>\n                    <jats:p>100 women undergoing IVF with embryo transfer. The primary outcome measure was the total number of oocytes retrieved per follicle, number of mature oocytes, and number of embryos generated. The secondary outcomes included clinical and biochemical pregnancy rates and incidence of ovarian hyperstimulation syndrome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Mean number of oocytes retrieved (6.5 \u00b1 4.0 vs. 6.4 \u00b1 3.9,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.3) and mean number of mature oocytes (4.0 \u00b1 2.3 vs. 3.2 \u00b1 2.3,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.09) were similar in the two groups; however, mean number of oocytes retrieved per follicle was found to be higher with 500 \u03bcg r-hCG (67.4 \u00b1 23.9 vs. 77.5 \u00b1 23.3,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.04). In the subgroup of poor responder women, there was a significant increase in the number of mature oocytes retrieved with double dose of r-hCG (2.2 \u00b1 1.8 vs. 3.7 \u00b1 1.9,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.06), leading to improvement in fertilization and clinical pregnancy rates.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Double dose of r-hCG for final follicular maturation in IVF cycles resulted in improvement in mean number of oocytes per follicle but did not result in improved pregnancy rates in the women. In the subset of poor responders, 500 \u03bcg r-hCG seems to be more advantageous than the lower dose, although larger randomized trials are needed to generalize this strategy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jhrs.jhrs_125_18","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T05:14:16Z","timestamp":1576473256000},"page":"310-315","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Does Double Dose of Recombinant Human Chorionic Gonadotropin for Final Follicular Maturation in In vitro Fertilization Cycles Improve Oocyte Quality: A Prospective Randomized Study"],"prefix":"10.4103","volume":"12","author":[{"given":"Neeta","family":"Singh","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavana","family":"Girish","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neena","family":"Malhotra","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reeta","family":"Mahey","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanamail","family":"Perumal","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,12,17]]},"reference":[{"key":"R1-20250521","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10815-005-4911-9","article-title":"A prospective, randomized and blinded comparison between 10,000 IU urinary and 250 microg recombinant human chorionic gonadotropin for oocyte maturation in in vitro fertilization cycles","volume":"22","author":"Abdelmassih","year":"2005","journal-title":"J Assist Reprod Genet"},{"key":"R2-20250521","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1093\/humrep\/15.6.1305","article-title":"A prospective, randomized, controlled, double-blind, double-dummy comparison of recombinant and urinary HCG for inducing oocyte maturation and follicular luteinization in ovarian stimulation","volume":"15","author":"Driscoll","year":"2000","journal-title":"Hum Reprod"},{"key":"R3-20250521","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0015-0282(01)01851-9","article-title":"Recombinant human chorionic gonadotropin (rhCG) in assisted reproductive technology: Results of a clinical trial comparing two doses of rhCG (Ovidrel) to urinary hCG (Profasi) for induction of final follicular maturation in in vitro fertilization-embryo transfer","volume":"76","author":"Chang","year":"2001","journal-title":"Fertil Steril"},{"key":"R4-20250521","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2004-2169","article-title":"A prospective, randomized, double-blind study to compare two doses of recombinant human chorionic gonadotropin in inducing final oocyte maturity and the hormonal profile during the luteal phase","volume":"90","author":"Chan","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R5-20250521","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1093\/humrep\/14.7.1703","article-title":"Recurrent empty follicle syndrome successfully treated with recombinant human chorionic gonadotrophin","volume":"14","author":"Pe\u00f1arrubia","year":"1999","journal-title":"Hum Reprod"},{"key":"R6-20250521","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0301-2115(03)00010-1","article-title":"The combination of urinary and recombinant HCG improves outcome in patients with decreased oocyte\/follicle ratio in previous cycles","volume":"109","author":"Littman","year":"2003","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R7-20250521","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1093\/humrep\/12.11.2385","article-title":"Evidence from a salvaged treatment cycle supports an aetiology for the empty follicle syndrome that is related to terminal follicular developmental events","volume":"12","author":"Meniru","year":"1997","journal-title":"Hum Reprod"},{"key":"R8-20250521","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10815-012-9919-3","article-title":"Comparing the efficacy of urinary and recombinant HCG on oocyte\/follicle ratio to trigger ovulation in women undergoing intracytoplasmic sperm injection cycles: A randomized controlled trial","volume":"30","author":"Madani","year":"2013","journal-title":"J Assist Reprod Genet"},{"key":"R9-20250521","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1177\/1933719116682873","article-title":"Dual triggering with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin in patients with a high immature oocyte rate","volume":"24","author":"Fabris","year":"2017","journal-title":"Reprod Sci"},{"key":"R10-20250521","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3109\/09513590.2011.652244","article-title":"Triggering ovulation with 250 \u03bcg or 500 \u03bcg of r-hCG in oocyte donors treated with antagonist protocol has no effect on the number of mature oocytes retrieved: A randomized clinical trial","volume":"28","author":"Clua","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"R11-20250521","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0015-0282(03)00173-0","article-title":"Use of recombinant human chorionic gonadotropin in ovulation induction","volume":"79","author":"Ludwig","year":"2003","journal-title":"Fertil Steril"}],"container-title":["Journal of Human Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jhrs.JHRS_125_18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:51:29Z","timestamp":1787773889000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jhrs.JHRS_125_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.4103\/jhrs.jhrs_125_18","relation":{},"ISSN":["0974-1208","1998-4766"],"issn-type":[{"value":"0974-1208","type":"print"},{"value":"1998-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"2018-09-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}